Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024.
- Revenue
- −0.49%
- EPS
- −10.6%
- Free cash flow
- −3.47%
- Total debt
- +8.09%
Quarter to September 2026, against a year earlier
Follow FMS
Alert me
Fresenius Medical Care AG & Co. KGaA (FMS) P/S ratio
As of 5 November 2026, Fresenius Medical Care AG & Co. KGaA (FMS) trades at a P/S ratio of 0.5×. Over the past ten years it has ranged from 0.4× (October 2022) to 1.8× (January 2018); the current reading is higher than 11% of that period. That is below the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.6× | (1.62%) |
| FY2024 | 0.6× | 7.21% |
| FY2023 | 0.6× | 28.12% |
| FY2022 | 0.5× | (49.33%) |
| FY2021 | 0.9× | (23.85%) |
| FY2020 | 1.2× | 5.18% |
| FY2019 | 1.1× | 12.09% |
| FY2018 | 1.0× | (36.35%) |
| FY2017 | 1.6× | 10.45% |
| FY2016 | 1.4× | (5.03%) |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 0.5× | (2.93%) |
| Jun 2026 | 0.5× | (3.17%) |
| Mar 2026 | 0.6× | (11.49%) |
| Dec 2025 | 0.6× | (11.79%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA | 0.5× |
| UHS Universal Health Services, Inc. compare | 0.6× |
| DVA DaVita Inc. compare | 0.9× |
| THC Tenet Healthcare Corporation compare | 1.0× |
| PACS PACS Group, Inc. compare | 1.4× |
| ENSG The Ensign Group, Inc. compare | 1.9× |
| EHC Encompass Health Corporation compare | 2.2× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.3× |
| CHE Chemed Corporation compare | 2.6× |
| Medical Care Facilities industry median | 1.0× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on FMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement